Tag
biotech
- Longeveron slides 59% after-hours from stem cell therapy study failure
- bioAffinity Technologies jumps 63% on Hong Kong lung cancer screening patent
- BioNTech's lung cancer drug outperforms chemo in clinical study
- Ultragenyx plunges after-hours from rare disease drug trial failure
- bioAffinity jumps 45% from lung cancer phlegm test expansion
- Revolution's newly approved drug doubles pancreatic cancer survival time
- Freenome gets FDA breakthrough designation for 'SimpleScreen' lung cancer blood test
- Sionna shares plummet after cystic fibrosis clinical trial failure
- Replimune tanks on FDA concerns about its skin cancer therapy
- CNS drug specialist Jupiter Neuro signs MDMA deal with PharmAla Biotech
- Pharma giant Eli Lilly enters psychedelics space with AtaiBeckley takeover
- Definium Therapeutics soars on Phase 3 trial win with LSD depression drug
- Psilera raises US$8.8M to fight dementia with non‑psychoactive psilocybin drug
- CNS Pharma sees 250% spike from oversubscribed private placement
- Optimi Health launches ibogaine initiative in response to Trump's executive order
- Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug
- bioAffinity Technologies soars Monday as non‑invasive lung cancer tech gains traction
- Immutep completely tanks after discontinuing lung cancer drug trial
- Kairos Pharma acquires lung cancer drug assets from Celyn Therapeutics
- Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test
- Pakistani cabinet approves national framework for medical cannabis regulation
- Enveric Biosciences skyrockets on patent allowance for psychedelic-inspired molecules
- Eli Lilly launches AI‑powered drug development platform for biotech operators
- Pharma giant AbbVie to spend over US$1B on Gilgamesh's lead psychedelic
- Y‑mAbs stock soars over 100% after acquisition deal with SERB S.A.S.
- Lantern Pharma completes Japanese enrolment for lung cancer drug trial
- Evoke Pharma skyrockets on patent allowance for diabetes nasal spray drug
- Mindstate Design Labs uses AI to provide customized psychedelic experiences
- Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease
- Intranasal delivery tech developer 'Polyrizon' plans to administer psychedelics
- MindBio Therapeutics uses AI speech analysis to see if you've taken its LSD drug
- Phio Pharmaceuticals skyrockets on skin cancer drug trial success
- IGM Biosciences slides by 66% on discontinued drug development and lay offs
- SILO Pharma flies high on impending patent for intranasal PTSD drug
- Hoth Therapeutics up over 218% on dermatology breakthrough for cancer patients
- RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement
- Neurogene patient dies in drug trial, stock surges after FDA says 'use lower dose'
- Breath Diagnostics onboards new president and closes critical financing
- Wave Life Sciences shares pop 50% on positive clinical data for common type of muscular dystrophy
- Breath Diagnostics pioneers novel lung cancer breath test
- ChitogenX completes opening phases of rotator cuff clinical trial
- Illumina invites genomics firm CEO to chat about future of healthcare